Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01242020 · ClinicalTrials.gov registry record · NA
Microvascular Flow Assessment Repeatability Study: The MARS Study
A NA study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01242020: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT01242020 is a NA study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01242020, a NA study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to test a method of imaging (taking a picture) of the abdomen (belly), neck, thigh and calf (lower leg) areas of the body, using ultrasound along with a drug which makes the pictures look clearer. Ultrasound is a type of imaging that uses sound waves to create a picture of the inside of the human body. Two sets of pictures will be taken on two different days to see if the results are the same each time. DEFINITY® is a drug given intravenously (through the vein). DEFINITY® is approved by the FDA to be used as an ultrasound contrast agent (makes the pictures look clearer) while taking pictures of the heart. In this study, DEFINITY® will be used while taking pictures of blood vessels in your abdomen (belly), neck, thigh and calf (lower leg). Since this use of DEFINITY® is different than the use approved by the FDA, this study will be performed under an FDA Investigational New Drug (IND) application.
Interventions
- DRUG Perflutren Lipid Microsphere Injectable Suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01242020
The ClinicalTrials.gov registry entry for NCT01242020 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Perflutren Lipid Microsphere Injectable Suspension is the first listed.
NCT01242020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01242020 about?
NCT01242020 is a clinical study titled "Microvascular Flow Assessment Repeatability Study: The MARS Study". The purpose of this study is to test a method of imaging (taking a picture) of the abdomen (belly), neck, thigh and calf (lower leg) areas of the body, using ultrasound along with a drug which makes the pictures look clearer. Ultrasound is a type of imaging that uses sound waves to create a picture ...
What is the current status of trial NCT01242020?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2011-01. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01242020?
The interventions under investigation include: Perflutren Lipid Microsphere Injectable Suspension (DRUG).
Who is sponsoring clinical trial NCT01242020?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.